The entire healthcare industry is undergoing a transformation in the wake of the COVID-19 pandemic, and the global wound care industry is no exception. As concerns about aged patients contracting COVID-19 increased, care delivery began a gradual shift toward a home setting. As a result, participants in the wound care industry are investing heavily in technologies and solutions that require minimal/no medical intervention and can be used patients/family/care providers.

Following the pandemic, the focus of the advanced wound care solution industry shifted from wound treatment and healing to early wound detection and prevention. The increasing rate of healthcare-acquired pressure injuries (HAPI) was one of the primary drivers of this change, as this nonreimbursable treatment creates a huge cost burden for hospitals. The lack of adequate hospital beds during the COVID-19 pandemic also reinforced the shift toward prevention of chronic wounds, such as pressure ulcers (PrU) or diabetic foot ulcers (DFU).